Sino Biopharmaceutical (01177) Announces October 2025 Monthly Return with No Changes in Share Capital
Bulletin Express
Nov 03
Sino Biopharmaceutical Limited (stock code 01177) disclosed its monthly return for the period ended 31 October 2025, showing that the authorized share capital remains at 30,000,000,000 ordinary shares with a par value of HKD 0.025 each, for a total of HKD 750,000,000. No changes were recorded during the reporting period.
The total issued shares also remained at 18,760,717,230, with no treasury shares as of the end of October. The report further indicates that there were no movements in share option schemes, warrants, convertibles, or any other arrangements to issue additional shares during the month.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.